SGC2085,1821908-48-8

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

SGC2085

CAS No. : 1821908-48-8

MCE 国际站：SGC2085

产品活性：SGC2085是一种具有高效性和选择性的CARM1抑制剂, IC₅₀值为50 nM。

研究领域：Epigenetics

作用靶点：Histone Methyltransferase

In Vitro: SGC2085 which features a methyl at position R1 and a 3,5-dimethylphenoxy at R2 has an IC₅₀ of 50 nM for CARM1 and is over 100-fold selective for CARM1 over PRMT6. These results indicate that the presence of a substituent at R1 is essential for potent and selective inhibition of CARM1. With the exception of PRMT6 (IC₅₀=5.2 μM), SGC2085 does not inhibit other PRMTs. Considering its small size (MW=312.4 Da), SGC2085 has an excellent selectivity profile, which can probably be further improved by exploiting differences in the binding sites of the two enzymes outside the arginine binding pocket. Compound SGC2085 also shows complete selectivity against a panel of 21 human protein methyltrans- ferases tested at three different concentrations (1,10, and 50 μM). To characterize the mechanism of action of SGC2085 in solution, IC₅₀ values are determined at various concentrations of SAM and peptide substrate. Increasing concentration of substrate peptide or cofactor does not affect IC₅₀ values, indicative of a noncompetitive mechanism of inhibition, which has been previously shown for other protein methyltransferase inhibitors binding at the substrate pocket. No cellular activity is observed for SGC2085 when tested up to 10 μM (48 h exposure in HEK293 cells), while methylation of BAF155 is abrogated by 10 μM of the dual CARM1/PRMT6 inhibitor MS049. We assume that the absence of cellular activity for SGC2085 is due to poor permeability.

相关产品：Bioactive Compound Library Plus  |  Epigenetics Compound Library  |  Histone Modification Research Compound Library  |  Anti-Cancer Compound Library  |  Reprogramming Compound Library  |  Anti-Blood Cancer Compound Library  |  Targeted Diversity Library  |  Tazemetostat  |  GSK126  |  GSK3326595  |  Pinometostat  |  3-Deazaneplanocin A hydrochloride  |  GSK3368715 dihydrochloride  |  EPZ015666  |  JNJ-64619178  |  EED226  |  GSK343  |  UNC0642  |  UNC1999  |  Chaetocin  |  EZM 2302  |  BIX-01294  |  MS023  |  UNC0379  |  CM-272  |  MM-102 TFA  |  UNC0638  |  SGC0946  |  EPZ031686  |  LLY-283  |  OICR-9429  |  EPZ020411 hydrochloride  |  PFI-2 hydrochloride  |  A-366  |  NSC 663284  |  A-196

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。